Cancer Research and Treatment : Impact Factor & More
eISSN: 2005-9256pISSN: 1598-2998
Share this on:
Key Metrics
CiteScore 
8.7
Eigenfactor
0.005 - 0.01
H-Index
52
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.72
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Research and Treatment
Cancer Research and Treatment Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | KOREAN CANCER ASSOCIATION |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Research and Treatment ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Research and Treatment
Genetic Variant at 6p21.1 Impairs APOBEC2 in Hypoxic Mitophagy via HIF-1α/BNIP3 in Gastric Cancer.
- 12 May 2026
- Cancer research and treatment
Distinct Evolutionary Dynamics of HER2-Ultralow Versus HER2-Null from Residual to Metastatic Disease in Non-pCR Breast Cancer.
- 12 May 2026
- Cancer research and treatment
Impact of Carboplatin-Free Interval on Hypersensitivity Risks in Solid Tumor Patients with Silent Sensitization.
- 8 May 2026
- Cancer research and treatment
Risk Prediction Based on Clinicopathologic Features in Korean Melanoma Patients by Machine Learning.
- 7 May 2026
- Cancer research and treatment
Gaps between Supportive Care Needs and Services in Korea: Experiences and Preferences of Patients with Advanced Cancer and Their Caregivers in the Hospital and at Home.
- 7 May 2026
- Cancer research and treatment
A Phase Ib/II Study of Pemigatinib in Combination with Paclitaxel in Patients with Gastric Cancer with FGFs/FGFRs Alterations.
- 4 May 2026
- Cancer research and treatment
Genetic Variant at 6p21.1 Impairs APOBEC2 in Hypoxic Mitophagy via HIF-1α/BNIP3 in Gastric Cancer.
- 12 May 2026
- Cancer research and treatment
Distinct Evolutionary Dynamics of HER2-Ultralow Versus HER2-Null from Residual to Metastatic Disease in Non-pCR Breast Cancer.
- 12 May 2026
- Cancer research and treatment
Impact of Carboplatin-Free Interval on Hypersensitivity Risks in Solid Tumor Patients with Silent Sensitization.
- 8 May 2026
- Cancer research and treatment
Risk Prediction Based on Clinicopathologic Features in Korean Melanoma Patients by Machine Learning.
- 7 May 2026
- Cancer research and treatment
Gaps between Supportive Care Needs and Services in Korea: Experiences and Preferences of Patients with Advanced Cancer and Their Caregivers in the Hospital and at Home.
- 7 May 2026
- Cancer research and treatment
A Phase Ib/II Study of Pemigatinib in Combination with Paclitaxel in Patients with Gastric Cancer with FGFs/FGFRs Alterations.
- 4 May 2026
- Cancer research and treatment
FAQs on Cancer Research and Treatment
How long has Cancer Research and Treatment been actively publishing? 
What is the publishing frequency of Cancer Research and Treatment?
How many articles did Cancer Research and Treatment publish last year?
What is the eISSN & pISSN for Cancer Research and Treatment?
What is Citescore for Cancer Research and Treatment?
What is the H Index for Cancer Research and Treatment ?
What is SNIP score for Cancer Research and Treatment?
What is the SJR for Cancer Research and Treatment?
Who is the publisher of Cancer Research and Treatment?
